[Survival of the hepatitis C virus in a dialysis population in Goiânia, Goiás].
The patients were 173, aged 10 to 70 years old. An Elisa II test was undertaken and 61 to 173 (35.3%) had positive test; when INNO-LIA test was made, soropositivity was 26% (44/173). Patients with anti-VHC antibodies have been kept on hemodialysis treatment for periods longer than negatives (p < 0.05). Neither drugs users, blood transfusions, sexual and aminotransferase activity were significantly correlated with the infection. There is an elevated prevalence of anti-VHC antibodies among chronic hemodialysis patients which seems to be related to the time that patients are on dialysis treatment.
Naghettini
A V
AV
Departamento de Pediatria e Puericultura da Faculdade de Medicina, Universidade Federal de Goiás, GO.
Daher
R R
RR
Martin
R M
RM
Doles
J
J
Vanderborght
B
B
Yoshida
C F
CF
Rouzere
C
C
D000293:Adolescent; D000328:Adult; D000368:Aged; D000410:Alanine Transaminase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D015415:Biomarkers / Q000097:blood; D001803:Blood Transfusion; D002648:Child; D005260:Female; D016174:Hepacivirus / Q000276:immunology*; D018937:Hepatitis C Antibodies / Q000097:blood*; D006801:Humans; D008297:Male; D008875:Middle Aged; D006435:Renal Dialysis
D015415:Biomarkers; D018937:Hepatitis C Antibodies; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase
Soroprevalência do vírus da hepatite C na população em diálise de Goiânia, GO.